Results 1 to 10 of about 7,952,783 (243)

Enhancement of doxorubicin anti-cancer activity by vascular targeting using IsoDGR/cytokine-coated nanogold [PDF]

open access: yesJournal of Nanobiotechnology, 2021
Background Gold nanospheres tagged with peptides containing isoDGR (isoAsp-Gly-Arg), an αvβ3 integrin binding motif, represent efficient carriers for delivering pro-inflammatory cytokines to the tumor vasculature.
Angelo Corti   +8 more
doaj   +2 more sources

Vascular Endothelial Cells: Heterogeneity and Targeting Approaches

open access: yesCells, 2021
Forming the inner layer of the vascular system, endothelial cells (ECs) facilitate a multitude of crucial physiological processes throughout the body. Vascular ECs enable the vessel wall passage of nutrients and diffusion of oxygen from the blood into ...
Jan K. Hennigs   +3 more
doaj   +2 more sources

Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer. [PDF]

open access: yesFront Immunol, 2018
Boosting natural immunity against malignant cells has had a major breakthrough in clinical cancer therapy. This is mainly due to the successful development of immune checkpoint blocking antibodies, which release a break on cytolytic anti-tumor-directed T-
Georganaki M, van Hooren L, Dimberg A.
europepmc   +2 more sources

Vascular Targeting of Radiolabeled Liposomes with Bio-Orthogonally Conjugated Ligands: Single Chain Fragments Provide Higher Specificity than Antibodies. [PDF]

open access: yesBioconjug Chem, 2018
Liposomes are a proven, versatile, and clinically viable technology platform for vascular delivery of drugs and imaging probes. Although targeted liposomes have the potential to advance these applications, complex formulations and the need for optimal ...
Hood ED   +5 more
europepmc   +2 more sources

Targeting vascular (endothelial) dysfunction [PDF]

open access: yesBritish Journal of Pharmacology, 2017
AbstractCardiovascular diseases are major contributors to global deaths and disability‐adjusted life years, with hypertension a significant risk factor for all causes of death. The endothelium that lines the inner wall of the vasculature regulates essential haemostatic functions, such as vascular tone, circulation of blood cells, inflammation and ...
A. Daiber   +8 more
semanticscholar   +3 more sources

Tumor rim cells: From resistance to vascular targeting agents to complete tumor ablation

open access: yesTumor Biology, 2017
Current vascular targeting strategies pursue two main goals: anti-angiogenesis agents aim to halt sprouting and the formation of new blood vessels, while vascular disrupting agents along with coaguligands seek to compromise blood circulation in the ...
Khaled Seidi   +2 more
doaj   +2 more sources

Multimodal imaging guided preclinical trials of vascular targeting in prostate cancer. [PDF]

open access: yesOncotarget, 2015
The high mortality rate associated with castration-resistant prostate cancer (CRPC) underscores the need for improving therapeutic options for this patient population.
Kalmuk J   +4 more
europepmc   +2 more sources

Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm. [PDF]

open access: yesACS Nano, 2014
Targeted nanomedicine holds promise to find clinical use in many medical areas. Endothelial cells that line the luminal surface of blood vessels represent a key target for treatment of inflammation, ischemia, thrombosis, stroke, and other neurological ...
Howard M   +5 more
europepmc   +2 more sources

Combination of vascular surgery with novel vascular targeting agents as cancer therapeutics [PDF]

open access: yesFrontiers in Oncology
Locally advanced solid tumors, characterized by complex involvement or encasement of major vascular structures, present a significant challenge in curative oncology. Achieving microscopically negative margins often mandates extensive surgical procedures,
Jianxin Dong   +3 more
doaj   +2 more sources

Vascular targeting of nanoparticles for molecular imaging of diseased endothelium. [PDF]

open access: yesAdv Drug Deliv Rev, 2017
Atukorale PU   +3 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy